[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:benign-skin-growth":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":14,"states":15},"Benign Skin Growth",1,[7],{"nct_id":8,"title":9,"phases":10,"status":11,"updated_at":12,"content_modified":13},"NCT07201376","Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically",[],"RECRUITING","2026-08-26T02:16:32.589113Z","2026-05-13T02:55:06.672399Z",[],[]]